StockNews.AI
SNES
StockNews.AI
124 days

SenesTech's Evolve™ Deployed in Chicago Neighborhoods

1. SenesTech expands EvolveTM deployment in Chicago to manage rodent population. 2. Chicago's program aims to control rats without toxic poisons. 3. New York City rat contraceptive pilot program launch expected soon. 4. Positive early consumption reports from Chicago deployment noted. 5. SenesTech focuses on humane pest population management through innovative solutions.

7m saved
Insight
Article

FAQ

Why Bullish?

The expansion of their Evolve product shows market acceptance. Historical precedent shows product deployments in urban areas boost stock performance.

How important is it?

The article highlights key deployments that could enhance revenue streams for SenesTech.

Why Short Term?

Immediate deployments can lead to rapid revenue increase. Community acceptance will likely influence sales quickly.

Related Companies

CLOVEVLVZETA
, /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions for managing rodent populations, today confirmed the expanding deployment of EvolveTM Rat Birth Control in the Wicker Park Bucktown Special Service Area of Chicago. The new program from the Wicker Park Bucktown Chamber of Commerce has crews installing bait boxes with Evolve Rat in alleys behind several major thoroughfares in the neighborhoods. The goal, according to Alice Howe, Special Service Area N. 33 Program Manager, is to control the rat population without the toxins and poisons that pose a risk to many other animals in the city as well as water supplies. The program, which garnered extensive media coverage, is the latest in SenesTech's rodent birth controlTM deployments. In September, the New York City Council voted to launch a rat contraceptive pilot program, which is expected to commence shortly. Other recent urban deployments of note have been in the Boston area and Baltimore. As part of SenesTech's partnership with Wicker Park Bucktown groups, the Company has launched a dedicated informational website for the residents and business owners, which can be accessed here. "This Chicago project is a perfect example of a commerce/citizen joint effort. They approached us with the problem, and our technical team worked with them on developing a plan. The early reports on consumption are positive, and we are already working on their second shipment as they expand the deployment area," said Joel Fruendt, President and CEO of SenesTech. About SenesTech, Inc. SenesTech is committed to creating healthier environments by humanely managing animal pest populations through fertility control. The company's groundbreaking products, including Evolve™ rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are humane, effective, and sustainable. For more information, visit https://senestech.com. Safe Harbor StatementThis press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, our expectation that the rat contraceptive pilot program in New York City will commence shortly.  Forward-looking statements may describe future expectations, plans, results, or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations; our ability to maintain compliance with Nasdaq's continued listing requirements; regulatory approval and regulation of our products; and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise. Investor Contact:Robert Blum, Lytham Partners, LLC(602) 889-9700, [email protected] Marketing Contact:Rochelle Paulet, SenesTech, Inc.(928) 779-4143, [email protected]  SOURCE SenesTech, Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News